cbdMD (YCBD) Net Income towards Common Stockholders (2016 - 2025)

cbdMD has disclosed Net Income towards Common Stockholders across 10 years of filings, most recently posting -$324602.0 for Q4 2025.

• Net Income towards Common Stockholders for Q4 2025 came in at -$324602.0, up 67.06% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.7 million (up 44.5% YoY), and the FY2025 annual result was -$4.4 million, up 43.21% from the prior year.
• Net Income towards Common Stockholders came in at -$324602.0 for Q4 2025 at cbdMD, up from -$679968.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $977007.0 in Q2 2021 to a low of -$32.6 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is -$2.6 million (2023), against an average of -$6.5 million.
• Across the five-year window, Net Income towards Common Stockholders jumped 110.79% in 2021 and sank 3440.27% in 2022, its largest moves.
• cbdMD's Net Income towards Common Stockholders stood at -$20.2 million in 2021, then jumped by 75.42% to -$5.0 million in 2022, then jumped by 59.71% to -$2.0 million in 2023, then surged by 50.66% to -$985406.0 in 2024, then surged by 67.06% to -$324602.0 in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$324602.0 (Q4 2025), -$679968.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.